Efficacy and safety of four dose regimes of a hypoallergenic recombinant birch pollen major allergen (rBet v 1-FV) in birch pollen allergic patients studied in an environmental exposure chamber

被引：0
|
作者：
Meyer, W. [1 ]
Narkus, A. [1 ]
Salapatek, A. [2 ]
Patel, D. [2 ]
Mussler, S. [1 ]
Haefner, D. [1 ]
机构：
[1] Allergopharma Joachim Ganzer KG, Dept Med, Reinbek, Germany
[2] Cetero Res, Med Affairs, Mississauga, ON, Canada
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
187
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [31] Dose-range finding of natural birch pollen exposure in patients with seasonal allergic rhinitis in the Fraunhofer Environmental Challenge Chamber
    Lueer, K.
    Windt, H.
    Schwarz, K.
    Badorrek, P.
    Sebastian, R.
    Haefner, D.
    Koch, W.
    Krug, N.
    Hohlfeld, J. M.
    ALLERGY, 2014, 69 : 73 - 73
  • [32] Transgenic Rice Seeds Accumulating Recombinant Hypoallergenic Birch Pollen Allergen Bet v 1 Generate Giant Protein Bodies
    Wang, Shuyi
    Takahashi, Hideyuki
    Kajiura, Hiroyuki
    Kawakatsu, Taiji
    Fujiyama, Kazuhito
    Takaiwa, Fumio
    PLANT AND CELL PHYSIOLOGY, 2013, 54 (06) : 917 - 933
  • [33] IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
    Paolucci, M.
    Sosic, L.
    Streuli, A.
    Melillo, D.
    Sousa-Augusto, G.
    Lang, C. C.
    Duda, A.
    Jiang, T.
    Campana, R.
    Bachmann, M.
    Schmid-Grendelmeier, P.
    Eyer, K.
    Kundig, T. M.
    Johansen, P.
    SWISS MEDICAL WEEKLY, 2024, 154 : 14S - 14S
  • [34] Caveolar transport through allergen Bet v 1 in allergic nasal epithelium of birch pollen patients
    Joenvaara, Sakari
    Mattila, Pirkko
    Renkonen, Jutta
    Makitie, Antti
    Toppila-Salmi, Sanna
    Lehtonen, Mikko
    Salmi, Paula
    Lehti, Satu
    Makinen, Jarno
    Sormunen, Raija
    Paavonen, Timo
    Renkonen, Risto
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (01) : 135 - 142
  • [35] Birch pollen allergen Bet v 1 binds to and is transported through conjunctival epithelium in allergic patients
    Renkonen, J.
    Mattila, P.
    Lehti, S.
    Makinen, J.
    Sormunen, R.
    Tervo, T.
    Paavonen, T.
    Renkonen, R.
    ALLERGY, 2009, 64 (06) : 868 - 875
  • [36] Profiling recombinant major birch pollen allergen Bet v 1a and carbamylated variants with CZE and CIEF
    Kronsteiner, Barbara
    Malissa, Hans, Jr.
    Stutz, Hanno
    ELECTROPHORESIS, 2007, 28 (13) : 2241 - 2251
  • [37] Harmonization of the Genetic Code Effectively Enhances the Recombinant Production of the Major Birch Pollen Allergen Bet v 1
    Asam, Claudia
    Roulias, Anargyros
    Parigiani, Maria A.
    Haab, Astrid
    Wallner, Michael
    Wolf, Martin
    Briza, Peter
    Bohle, Barbara
    Ferreira, Fatima
    Hauser, Michael
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 177 (02) : 116 - 122
  • [38] Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1
    Daniel, C.
    Repa, A.
    Wild, C.
    Pollak, A.
    Pot, B.
    Breiteneder, H.
    Wiedermann, U.
    Mercenier, A.
    ALLERGY, 2006, 61 (07) : 812 - 819
  • [39] Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma
    Tourdot, Sophie
    Airouche, Sabi
    Berjont, Nathalie
    Moussu, Helene
    Betbeder, Didier
    Nony, Emmanuel
    Bordas-Le Floch, Veronique
    Baron-Bodo, Veronique
    Mascarell, Laurent
    Moingeon, Philippe
    VACCINE, 2013, 31 (23) : 2628 - 2637
  • [40] A hypoallergenic variant of the major birch pollen allergen Bet v 1 shows distinct characteristics in antigen processing and T cell activation
    Kitzmueller, C.
    Wallner, M.
    Deifl, S.
    Mutschlechner, S.
    Zlabinger, G.
    Ferreira, F.
    Bohle, B.
    IMMUNOLOGY, 2012, 137 : 435 - 435
12345